IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Stanley-Laman Group, Ltd.

Q1 2018 Holdings

Filed 2018-05-01 | 262 holdings | $31.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Alibaba Group Hldg F Sponsored ADR 1 ADR Reps 1 ORD SHS(BABA)SPONSORED ADS01609W102$221.0K1,2030.7%
Conocophillips(COP)COM20825C104$267.0K4,4980.8%
Acadia Pharmaceutl(ACAD)COM004225108$313.0K13,9461.0%
Aldeyra Therapeutics(ALDX)COM01438T106$480.0K64,0291.5%
Advansix Inc(ASIX)COM00773T101$677.0K19,4592.1%
Abbvie Inc(ABBV)COM00287Y109$1.9M20,1056.0%
Crown Castle Intl Co REIT(CCI)COM22822V101$2.2M20,5077.1%
Akebia Therapeutics(AKBA)COM00972D105$3.0M314,4019.4%
Cisco Systems Inc(CSCO)COM17275R102$3.4M80,40510.9%
Biomarin Pharmaceutl(BMRN)COM09061G101$5.1M62,51716.0%
Darling Ingredients(DAR)COM237266101$5.7M327,95917.9%
Curtiss Wright Corp(CW)COM231561101$8.0M59,24725.2%
PreviousPage 6 of 6